Leptin treatment: Facts and expectations
Year: 2014
Type: review
Abstract: Leptin has key roles in the regulation of energy balance, body weight, metabolism, and endocrine function. Leptin levels are undetectable or very low in patients with lipodystrophy, hypothalamic amenorrhea, and congenital leptin deficiency (CLD) due to mutations in the leptin gene. For these patients, leptin replacement therapy with metreleptin (a recombinant leptin analog) has improved or normalized most of their phenotypes, including normalization of endocrine axes, decrease in insulin resistance, and improvement of lipid profile and hepatic steatosis. Remarkable weight loss has been observed in patients with CLD. Due to its effects, leptin therapy has also been evaluated in conditions where leptin levels are normal or high, such as common obesity, diabetes (types 1 and 2), and Rabson-Mendenhall syndrome. A better understanding of the physiological roles of leptin may lead to the development of leptin-based therapies for other prevalent disorders such as obesity-associated nonalcoholic fatty liver disease, depression and dementia.
Source: Metabolism
Language: English
Subfield: Endocrine and Autonomic Systems
Field: Neuroscience
Domain: Life Sciences
Keywords: leptin, metreleptin, leptin replacement therapy, lipodystrophy, hypothalamic amenorrhea, congenital leptin deficiency, insulin resistance, hepatic steatosis, obesity, type 1 diabetes, type 2 diabetes, Rabson-Mendenhall syndrome, non-alcoholic fatty liver disease, depression, dementia, energy balance
Open Access status: hybrid
Estimated APC paid: $5,340
OpenAlex ID: W2027112907
